v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit
The following table presents Recursion’s segment revenue, significant segment expenses, and segment net loss:

Three months ended March 31,
(In thousands)20262025
Revenue$6,472 $14,745 
Significant segment expenses
Salaries74,298 83,554 
Consumables7,146 54,677 
Platform7,614 8,765 
Discovery6,332 6,287 
Clinical development6,569 10,564 
Depreciation and amortization19,673 19,331 
Other segment items13,345 22,935 
Loss from operations128,505 191,368 
Other non-operating income (loss), net6,397 (11,277)
Income tax benefit4,604 158 
Total segment loss$117,504 $202,487 
Supplemental asset information
Total expenditures for additions to long-lived assets$258 $2,978